Choosing the Right Depression Model: A Translational Framework for Antidepressant Research

Major Depressive Disorder (MDD) affects over 300 million individuals globally. Translating novel psychiatric therapeutics into clinical efficacy remains highly challenging due to complex pathophysiology, biological heterogeneity, and poor translational predictability of traditional models. This comprehensive white paper establishes a strategic framework for matching antidepressant therapeutic candidates with mechanism-relevant animal models.

Why Download This Guide?

• In-depth Comparison: Evaluate strengths and limitations of CUMS, CSDS, LPS, and genetic models.
• Protocol Standardization: Learn key strategies to minimize inter-laboratory variability in CUMS studies.
• Translational Endpoints: Bridge the gap between behavioral efficacy and molecular biomarker validation.
• Case Study Data: Review dosage-response efficacy curves for standard reference compounds (e.g., Fluoxetine).

Fill out the form below to download our comprehensive white paper and gain actionable insights into psychiatric drug development.